Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

etic mechanisms co-operate to silence key tumor suppressor genes in cancer, we are able to choose epigenetic drugs from within our portfolio to combine and attack these silencing systems simultaneously, with encouraging clinical data emerging in the context of acute myeloid leukemia."

Pharmion has three epigenetic products in its portfolio, including Vidaza(R) (azacitidine for injection), MGCD0103 and oral Azacitidine. Pharmion currently markets Vidaza, its parenteral formulation of Azacitidine, in the U.S. and several additional countries for the treatment of patients with MDS. Abstracts presented at this year's ASCO meeting will address the pharmacokinetics of oral Azacitidine administration, and report data from studies investigating Vidaza's utility in MDS, including alternative dosing schedules and in the treatment of MDS patients with marrow fibrosis.

Additionally, accepted abstracts will investigate the use of Vidaza as part of combination treatment regimens with other epigenetic therapies, including interim results from an ongoing study with MGCD0103, for the treatment of high-risk MDS and acute myeloid leukemia (AML), and in combination with valproic acid in advanced solid tumors.

An oral presentation on a study of MGCD0103 in relapsed/refractory Hodgkin's lymphoma will be presented during ASCO, as will a poster on the use of MGCD0103 as a single agent in patients with MDS or leukemias. Pharmion has a licensing and collaboration agreement with MethylGene for MGCD0103, as well as MethylGene's pipeline of second-generation HDAC inhibitor compounds for oncology indications.

Data from a first-line study evaluating the addition of Thalidomide to the standard of care for elderly multiple myeloma patients will be the subject of an oral presentation at the 2007 ASCO meeting, where a total of three oral presentations and six posters on Thalidomide studies will be presented. Data from the oral presentation reinforce the substantial body of
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:6/17/2013)... , June 17, 2013 ... China Pharmaceutical Guidebook: Latest Chinese Regulations ... ).      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) ... possesses a fourth population in ... the largest drug markets round the ...
(Date:6/17/2013)... --  Southern Research Institute today announced that ... its Board of Directors to serve as president and ... (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ) ... served as president and CEO of Southern Research Institute ... year after 34 years of service at Southern Research. ...
(Date:6/17/2013)... SYDNEY , June 17, 2013 ... ASX: HIN), a leading innovator of less invasive, ... treatment of advanced heart failure, today announced that ... granted conditional approval to an IDE (Investigational Device ... in an additional patient cohort for ENDURANCE, the ...
Breaking Medicine Technology:China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 2China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 3China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 4Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 2HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 3HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 4
... NOTTINGHAM, England, January 23, 2012 BACDT and ... on his way to Uganda to help set up a ... Christian Relief Uganda. The trip has been arranged ... time the charities have worked with a Clinical Dental Technician ...
... Calif., Jan. 23, 2012 ThermoGenesis Corp. (NASDAQ: ... that process and store adult stem cells, said today, it ... System from a new public cord blood bank that will ... Blood Services, a national charitable organization that manages the supply ...
Cached Medicine Technology:BACDT Member Mark Melbourne off to Uganda With Dentaid and Christian Relief 2Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 2Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 3Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 4
(Date:6/17/2013)... The Professional Center for Enhanced Performance ... open in Schertz. The center will offer ... to educational support groups. , Neurofeedback treatment is ... with athletic performance, post traumatic stress disorder, and ... LCSW, works primarily with those affected by military ...
(Date:6/17/2013)... cancer treatment often lose their fertility because chemotherapy ... ovarian eggs, called oocytes. Now, Northwestern Medicine scientists ... the death of immature ovarian eggs due to ... Scientists achieved this in female mice by adding ... another chemotherapy drug cisplatin. , The results will ...
(Date:6/17/2013)... Each year, millions of patients seek treatment for vein ... Specialists in Winston-Salem, NC is spreading the word about new ... safer and more effective. , Vein treatment has come ... patients may think they know from past experience could well ... off diseased veins permanently, allowing them to be gradually reabsorbed ...
(Date:6/17/2013)... Reliable services of Link to Pay have been offered ... that can fix payment processing. , Schools and colleges have ... Collecting fees from students and processing them may be a ... such cases, colleges and universities are looking for some smart ... out efficiently without any complications. , At the same time, ...
(Date:6/17/2013)... are more likely than their normal-weight counterparts to ... new study. Findings showed that obese adolescents had ... almost twice as likely to have unilateral (one-sided) ... by The Laryngoscope , a journal published ... , "This is the first paper to ...
Breaking Medicine News(10 mins):Health News:Professional Center for Enhanced Performance Opens in Schertz 2Health News:Preventing eggs' death from chemotherapy 2Health News:Novant Health & Vein Specialists Educates Public About Safer, More Advanced Vein Treatments through Social Media Efforts 2Health News:PayCanada Offers Link to Pay Services to its Customers 2Health News:Obesity associated with hearing loss in adolescents 2Health News:Obesity associated with hearing loss in adolescents 3
... of Entries Available Through Charities and Tour Groups, ... announced today that,registration for the Bank of America ... on to complete the 26.2-mile race, marking the ... still available,through affiliated charities and tour groups., ...
... HILL, N.C., April 23 Global leaders are,rediscovering ... a powerful tool for competing in today,s economic,environment, ... Best Practices, LLC.,The study further reveals -- Competitive ... process of transforming raw competitive data,into actionable insights ...
... people with these headaches suffer from skin discomfort, study ... who have migraines -- either chronic or episodic -- ... and sensitivity, new research shows. , As many as ... a condition called cutaneous allodynia. Cutaneous allodynia is skin ...
... who care for older adults need our support.,The pressure ... With little free time and few resources, caregivers are ... April 23 In addition to their,primary jobs in ... taking,on the additional role of caregiver to others., ...
... and Industry Directions Launch New Study, FALLS ... and Industry Directions Inc., in close,association with research ... to respond to a new survey on current ... objectives,business processes and practices, information systems and applications, ...
... 23 Perrigo Company,(Nasdaq: PRGO ; TASE) today ... quarter fiscal 2008 on Tuesday, May 6, 2008 at ... call at 10:00 a.m.,(ET) hosted by Joseph C. Papa, ... will be available live via webcast to interested,parties on ...
Cached Medicine News:Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2Health News:Skin Pain, Sensitivity Rises With Migraine 2Health News:Skin Pain, Sensitivity Rises With Migraine 3Health News:'2008 Caregiving Conferences' Come to Wayne County, Offering Free Workshops and Resources in Canton and Taylor Locations 2Health News:Risk Management: Best Practices for Medical Device Profitability 2
... InSync Sentry cardiac resynchronization therapy (CRT) ... implantable medical therapy offering automatic fluid status ... area encompassing the lungs and heart. This ... advantage in managing heart failure, since thoracic ...
... Tamtron PowerPath is IMPACs comprehensive ... anatomic pathology laboratories to integrate and ... needs through a single, intuitive software ... more than 350 institutions have proven ...
The most compact revolutionary innovation in hematology. 8 or 18 automated parameter hematology analyzer....
... needs of its users for onboard data management ... latest development in its haematology analyser range, the ... new features, the PENTRA XL 80 incorporates all ... fully automated throughput of 80 samples per hour ...
Medicine Products: